Price
CHART BY
Frequently asked questions
What is Twist Bioscience's market capitalization?
The market capitalization of Twist Bioscience is $8.62B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Twist Bioscience?
Twist Bioscience's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$2.224. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Twist Bioscience's stock?
Currently, 10 analysts cover Twist Bioscience's stock, with a consensus target price of $116.67. Analyst ratings provide insights into the stock's expected performance.
What is Twist Bioscience's revenue over the trailing twelve months?
Over the trailing twelve months, Twist Bioscience reported a revenue of $431.80M.
What is the EBITDA for Twist Bioscience?
Twist Bioscience's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$112.38M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Twist Bioscience?
Twist Bioscience has a free cash flow of -$93.12M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Twist Bioscience have, and what sector and industry does it belong to?
Twist Bioscience employs approximately 979 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Twist Bioscience's shares?
The free float of Twist Bioscience is 63.74M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $8.62B
- EPS (TTM)
- -$2.224
- Free Float
- 63.74M
- Revenue (TTM)
- $431.80M
- EBITDA (TTM)
- -$112.38M
- Free Cashflow (TTM)
- -$93.12M
Pricing
- 1D span
- $123.98$130.80
- 52W span
- $23.50$155.42
Analyst Ratings
The price target is $116.67 and the stock is covered by 10 analysts.
Buy
9
Hold
1
Sell
0
Information
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.
- Employees
- 979
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- Primary Ticker
- TWST
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet